Association of serotype with risk of death due to pneumococcal pneumonia: A meta-analysis

Clinical Infectious Diseases

Volumn 51, Issue 6, 2010, Pages 692-699

  Weinberger, Daniel M ^a   Harboe, Zitta B ^d   Sanders, Elisabeth A M ^e   Ndiritu, Moses ^g   Klugman, Keith P ^b,i   Rückinger, Simon ^f   Dagan, Ron ^j   Adegbola, Richard ^h   Cutts, Felicity ^h   Johnson, Hope L ^c   O'Brien, Katherine L ^c   Scott, J Anthony ^g   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b EMORY UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d STATENS SERUM INSTITUT   (Denmark)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY OF MUNICH   (Germany)

^g KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^h MEDICAL RESEARCH COUNCIL   (United Kingdom)

ⁱ Respiratory and Meningeal Pathogens Research Unit   (South Africa)

^j BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM ISOLATE; CAUSE OF DEATH; COMORBIDITY; HUMAN; PNEUMOCOCCAL MENINGITIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW;

BACTERIAL TYPING TECHNIQUES; HUMANS; MENINGITIS, PNEUMOCOCCAL; MORTALITY; PNEUMONIA, PNEUMOCOCCAL; RISK ASSESSMENT; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 77955978715     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/655828     Document Type: Article

References (37)

1. Kadioglu A,Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008; 6:288-301.
2. Bogaert D, de Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004; 4: 144-154. (Pubitemid 38293138)
3. HausdorffWilliam P, Bryant J, Paradiso Peter R, Siber George R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30:100-121. (Pubitemid 30067069)
4. O'Brien KL. Pneumococcal regional serotype distribution for pneumococcal AMC TPP. http://www.vaccineamc.org/files/TPP-Codebook.pdf. Accessed 2009.
5. Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in Children. J Infect Dis 2004; 190:1203-1211.
6. Sjostrom K, Spindler C, Ortqvist A, et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 2006; 42:451-459.
7. Heffron R. Pneumonia: with special reference to pneumococcus lobar pneumonia. Cambridge, MA: Harvard University Press, 1979.
8. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964;60:759.
9. Alanee S, McGee L, Jackson D, et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 2007; 45:46-51.
10. Berg S, Trollfors B, Persson E, et al. Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics. Scand J Infect Dis 2006; 38:427-432.
11. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009; 6(5)::e1000081.
12. Rückinger S, von Kries R, Siedler A, van der Linden M. Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome. Pediatr Infect Dis J 2009; 28:118-122.
13. Martens P, Worm S, Lundgren B, Konradsen H, Benfield T. Serotypespecific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis 2004; 4:21.
14. Briles DE, Crain MJ, Gray BM, Forman C, Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 1992; 60:111-116.
15. MacLeod CM, Krauss MR. Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro. J Exp Med 1950; 92:1-9.
16. Magee AD, Yother J. Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun 2001; 69:3755-3761.
17. Cruickshank R. Pneumococcal infections. Lancet 1933; 221:563-569.
18. Weinberger DM, Trzcinski K, Lu Y-J, et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 2009; 5: e1000476.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials: controlled clinical trials 1986; 7:177-188.
20. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60:759-776.
21. Mufson MA, Kruss DM, Wasil RE, Metzger WI. Capsula types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 1974; 134:505-510.
22. Jansen A, Rodenburg G, van der Ende A, et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis 2009; 49:e23-e9.
23. Antonio M, Dada-Adegbola H, Biney E, et al. Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis 2008; 8:81.
24. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
25. Sleeman KL, Griffiths D, Shackley F, et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 2006; 194:682-688.
26. Cheung Y-BP, Zaman SMAP, Nsekpong EDB, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Pediatr Infect Dis J 2009; 28:990-995.
27. Bogaert D, Sluijter M, Toom N, et al. Dynamics of pneumococcal colonization in healthy Dutch children. Microbiology 2006; 152:377-385.
28. Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005; 116: e408-e413.
29. Kellner JD, Ford-Jones EL; Members of the Toronto Child Care Centre Study Group. Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Arch Pediatr Adolesc Med 1999; 153: 495-502.
30. Abdullahi O, Nyiro J, Lewa P, Slack M, Scott JA. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J 2008; 27:59-64.
31. Ring A, Weiser J, Tuomanen E. Pneumococcal trafficking across the blood-brain barrier: molecular analysis of a novel bidirectional pathway. J Clin Invest 1998; 102:347-360.
32. Bullowa J. Management of pneumonias. New York: Oxford University Press, 1937.
33. Finland M. Significance of specific pneumococcus types in disease, including types IV to XXXII (Cooper). Ann Intern Med 1937; 10:1531.
34. Raia A, Shultz S. New types of pneumococci in the pneumonias of children. Am J Dis Child 1931; 42:57-68.
35. Henriques B, Kalin M, Ortqvist A, et al. Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis 2000; 182:833-839.
36. Mirzanejad Y, Roman S, Talbot J, Nicolle L. Pneumococcal bacteremia in two tertiary care hospitals in Winnipeg, Canada. Chest 1996; 109: 173-178.
37. Briles DE, Crain MJ, Gray BM, Forman C, Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 1992; 60:111-116.